Addition of Radiotherapy to the Primary Tumour in Oligometastatic NSCLC: A Systematic Review and Meta-Analysis

Advanced non-small cell lung cancer (NSCLC) remains an almost incurable disease, with prognosis significantly improved with the advent of immunotherapy that has increased overall survival (OS) in both first and subsequent lines of therapy. Recently, the availability of more focused radiation delivery in the form of stereotactic body radiation therapy (SBRT) has permitted the treatment of both primary and distant metastases in particular when oligometastatic sites of disease permit aggressive local therapy (e.g.
Source: Lung Cancer - Category: Cancer & Oncology Authors: Tags: Review Source Type: research